CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial, 2026, Albach et al.

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial Spoiler: Authors Albach, Fredrik N.; Rehm, Marie C.; Hütter-Krönke, Marie Luise; Le, Thanh Hang; Giezen, Julia M.; Torgutalp, Murat; Sattler, Arne; Minopoulou, Ioanna; Biesen, Robert; Wiebe, Edgar; Casteleyn, Vincent; Witte, Thorben; Furth, Christian; Zernicke, Jan; Nuesch Germano, Melanie;…